MedWatch

Danish-Swiss company in lucrative collaboration.

Danish-Swiss Evolva has struck a deal with a Japanese company that could result in several millions for the company.

Foto: Colourbox

Japanese Ajinomoto, one of the world leaders within amino acids, has signed a three and a half year long collaboration deal with Evolva.

The purpose of the collaboration is to “develop new methods for producing a natural functional ingredient to use in personal care through fermentation”, the companies write in a joint statement.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier